Home > USA > Investors > ASX Announcements
 
 
 
HomeAbout UsProducts & TechnologyCliniciansPatients & FamiliesMedia CentreInvestor Centre
 
 
Investor Centre
 
Welcome'width='178
Corporate Profile
Investor Fact Sheet
Share Price Information
ASX Announcements
SEC Filings
News Releases
Annual Reports
Corporate Presentations
Events Calendar
Corporate Governance
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations
 
 
 
 
 
  ASX Announcements
 
 

Email Alerts Receive Email Alerts | RSS RSS Feeds
Keyword Search
 
2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
09/06/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
09/06/10FDA Grants HeartWare Second Patient Allotment Under CAPPrinter Friendly Version
08/19/10Option Grant - ASX Appendix 3BPrinter Friendly Version
08/19/10Option Exercise - ASX Appendix 3B Printer Friendly Version
08/12/10HeartWare Study to be Late-Breaker at American Heart Assn.Printer Friendly Version
08/09/10Appendix 4D and Half Year Financial Statements (US GAAP)Printer Friendly Version
08/06/10HeartWare Announces Second Quarter ResultsPrinter Friendly Version
08/05/10HeartWare to Present at Canaccord Growth ConferencePrinter Friendly Version
07/30/10HeartWare to Present at Wedbush Best Ideas ConferencePrinter Friendly Version
07/28/10Second Quarter Earnings Release CallPrinter Friendly Version
07/07/10Amended ASX Appendix 3BsPrinter Friendly Version
07/02/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
07/02/10Option Grant - ASX Appendix 3BPrinter Friendly Version
06/25/10Announces Board SuccessionPrinter Friendly Version
06/18/10HeartWare to present at Wells FargoPrinter Friendly Version
06/18/10Exercise of Options - ASX Appendix 3BPrinter Friendly Version
06/15/10HeartWare To Commence Destination Therapy TrialPrinter Friendly Version
06/07/10Exercise and Cancellation of OptionsPrinter Friendly Version
05/07/10Change of Director`s Interest NoticesPrinter Friendly Version
05/05/10Annual General Meeting ResultsPrinter Friendly Version
05/05/10Grant of Incentive Equity - Appendix 3BPrinter Friendly Version
05/05/10Annual General Meeting MaterialsPrinter Friendly Version
05/05/10Appendix 3BPrinter Friendly Version
05/05/10First Quarter 2010 Financial StatementsPrinter Friendly Version
05/04/10First Quarter ResultsPrinter Friendly Version
05/03/10Appendix 3BPrinter Friendly Version
04/27/10Initiates voluntary repairs and recalls certain controllersPrinter Friendly Version
04/27/10First 100 Patient Commercial and Clinical DataPrinter Friendly Version
04/12/10Heartware to Report Financial Results First Quarter of 2010Printer Friendly Version
04/12/10Notice of Annual General MeetingPrinter Friendly Version
04/08/10FDA Approves Continued Access Protocol for BTTPrinter Friendly Version
03/26/10Amended ASX Appendix 3BPrinter Friendly Version
03/24/10Change of Director`s Interest NoticePrinter Friendly Version
03/24/10Appendix 3B - Exercise of Stock OptionsPrinter Friendly Version
03/05/10HeartWare to Present at Annual Roth Growth ConferencePrinter Friendly Version
03/03/10Grant and Cancellation of Equity - ASX Appendix 3BPrinter Friendly Version
03/03/10Change of Director's Interest NoticePrinter Friendly Version
03/03/10Appendix 3B - Vesting of Preformance RightsPrinter Friendly Version
02/24/10Annual Report for 2009 and ASX Appendix 4EPrinter Friendly Version
02/23/10Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2MPrinter Friendly Version
02/23/10Enrollment of US Bridge to Transplant Trial CompletedPrinter Friendly Version
02/09/10Fourth Quarter and Annual Results for 2009 Earnings CallPrinter Friendly Version
02/03/10Completion of US$62 million Capital RaisingPrinter Friendly Version
02/03/10Capital Raising - Cleansing NoticePrinter Friendly Version
02/03/10Capital Raising - ASX Appendix 3B AllotmentPrinter Friendly Version
02/01/10Exercise and Cancellation of OptionsPrinter Friendly Version
01/28/10Pricing of Public Offering of Common StockPrinter Friendly Version
01/27/10Prospectus for Public Offering of HeartWare Common StockPrinter Friendly Version
01/27/10Public Offering of HeartWare Common StockPrinter Friendly Version
01/12/10Shareholder UpdatePrinter Friendly Version
01/04/10Thoratec Loan Facility UpdatePrinter Friendly Version
12/10/09Exercise of Options - Appendix 3BPrinter Friendly Version
12/08/09Change of Director's Interest NoticePrinter Friendly Version
12/02/09Exercise of Expiring Incentive OptionsPrinter Friendly Version
11/24/09HeartWare files IDE for Destination TherapyPrinter Friendly Version
11/23/09Change of Director's Interest NoticePrinter Friendly Version
11/23/09Exercise of (Expiring) OptionsPrinter Friendly Version
11/17/09Change of Director`s Interest NoticesPrinter Friendly Version
11/17/09Exercise of Options - ASX Appendix 3BPrinter Friendly Version
11/10/09Change of Contact Details for HeartWarePrinter Friendly Version
11/09/09CEO Presenting at Investment ConferencesPrinter Friendly Version
11/06/09HeartWare to Present at Upcoming Investment Conferences in NovemberPrinter Friendly Version
11/05/09Revenues of US$7.5M for Quarter Ended 30 September 2009Printer Friendly Version
11/05/09Financial Statements for September 30, 2009Printer Friendly Version
10/29/09Advance Notice of Q3 Earnings CallPrinter Friendly Version
10/27/09Capital Raising Allotment - ASX Appendix 3BPrinter Friendly Version
10/27/09Stockholder Meeting Results - Capital Raising ApprovedPrinter Friendly Version
10/27/09Cleansing Notice for Capital RaisingPrinter Friendly Version
10/06/09FDA Approves Expansion to 40 Sites for US BTT TrialPrinter Friendly Version
10/05/09Exercise of Incentive OptionsPrinter Friendly Version
09/23/09Notice of Special Meeting of Stockholders - Capital RaisingPrinter Friendly Version
09/21/09Annual Employee Equity AllocationPrinter Friendly Version
09/21/09Exercise and Cancellation of OptionsPrinter Friendly Version
09/07/09Option Exercise and CancellationsPrinter Friendly Version
09/02/09Reinstatement to Official QuotationPrinter Friendly Version
09/02/09Half Yearly Report / Accounts and Review ReportPrinter Friendly Version
08/21/09HeartWare Surpasses 50 US ImplantsPrinter Friendly Version
08/18/09Cleansing Notice for US$60 Miliion PlacementPrinter Friendly Version
08/18/09Closes US$60 Million PlacementPrinter Friendly Version
08/17/09ASX Appendix 4D And Half Year Financial Statements (US GAAP)Printer Friendly Version
08/11/09US$55 Million Capital RaisingPrinter Friendly Version
08/03/09Joint Termination of MergerPrinter Friendly Version
07/31/09Change of Directors Interests - Annual Meeting Stock IssuePrinter Friendly Version
07/31/09Issue of Stock Pursuant to Annual Meeting ApprovalPrinter Friendly Version
07/31/09Quarterly Update And ASX Appendix 4CPrinter Friendly Version
07/30/09Annual Meeting ResultsPrinter Friendly Version
07/30/09US FTC to Challenge Thoratec Acquisition of HeartWarePrinter Friendly Version
07/30/09Trading HaltPrinter Friendly Version
07/30/09Annual Meeting MaterialsPrinter Friendly Version
07/29/09Annual Meeting to be WebcastPrinter Friendly Version
07/21/09Change of Interests in Securities for Executive DirectorPrinter Friendly Version
07/06/09Appendix 3B - Vesting of RSUsPrinter Friendly Version
07/02/09Appendix 3BPrinter Friendly Version
06/18/09Appendix 3BPrinter Friendly Version
06/17/09Revised Thoratec Merger DocumentationPrinter Friendly Version
06/12/09Notice of Annual General Meeting/Proxy FormPrinter Friendly Version
05/12/09CEO Presenting at JMP Securities Research ConferencePrinter Friendly Version
05/12/09Quarterly Financial Statements 31 March 2009Printer Friendly Version
05/11/09Thoratec Files Registration StatementPrinter Friendly Version
05/08/09Thoratec Files Registration StatementPrinter Friendly Version
04/30/09Quarterly Update April 2009 and ASX Appendix 4CPrinter Friendly Version
04/24/09European Clinical Data UpdatePrinter Friendly Version
03/31/09First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment UpdatePrinter Friendly Version
03/27/09Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade CommissionPrinter Friendly Version
03/18/09Appendix 3BPrinter Friendly Version
02/27/092008 Annual Financial ReportPrinter Friendly Version
02/27/092008 Preliminary Final ReportPrinter Friendly Version
02/20/09NASDAQ Listing ConfirmationPrinter Friendly Version
02/19/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/18/09Additional Merger DocumentationPrinter Friendly Version
02/16/09HeartWare to be Acquired By Thoratec Corporation for US$282Printer Friendly Version
02/13/09Trading HaltPrinter Friendly Version
02/10/09First Implants at Northwestern MemorialPrinter Friendly Version
02/06/09Co-PI Appointed for US Clinical TrialPrinter Friendly Version
01/30/09Quarterly Report and CEO LetterPrinter Friendly Version
01/30/09CE Mark Approval receivedPrinter Friendly Version
01/13/09J P Morgan Healthcare Conference PresentationPrinter Friendly Version
12/31/08Cancellation of OptionsPrinter Friendly Version
12/17/08Principal Investigator Appointed for US Clinical TrialPrinter Friendly Version
12/05/08Enrollment of International Trial CompletedPrinter Friendly Version
12/04/08NASDAQ Dual Listing FilingPrinter Friendly Version
11/20/08MVAD & HVAD UpdatePrinter Friendly Version
11/20/082nd US Clinical Site Commences ImplantsPrinter Friendly Version
11/18/08CEO Healthcare Conference PresentationsPrinter Friendly Version
11/07/08Initial Directors Interest NoticePrinter Friendly Version
11/05/08HeartWare Group Redomiciliation and Trading of CDIsPrinter Friendly Version
11/03/08Date of Allotment of CDI SecuritiesPrinter Friendly Version
11/03/08Indicative Top 20 HoldersPrinter Friendly Version
11/03/08Admission to the Official ListPrinter Friendly Version
11/03/08Lodgement of Court Orders with ASICPrinter Friendly Version
10/31/08Quarterly Update And ASX Appendix 4CPrinter Friendly Version
10/30/08Federal Court Approval of Schemes of ArrangementPrinter Friendly Version
10/24/08Cleveland Clinic PresentationPrinter Friendly Version
10/22/08Redomiciliation Meeting MaterialsPrinter Friendly Version
10/22/08Redomiciliation Meeting ResultsPrinter Friendly Version
10/20/08Awarded ISO CertificationPrinter Friendly Version
10/15/08Medical Conference PresentationsPrinter Friendly Version
10/03/08Non-Executive Director AppointedPrinter Friendly Version
10/03/08Initial Directors Interest NoticePrinter Friendly Version
09/25/08Cancellation of OptionsPrinter Friendly Version
09/23/08FDA Grants Full IDE Approval in the United StatesPrinter Friendly Version
09/22/08Redomiciliation Documents Dispatched to ShareholdersPrinter Friendly Version
09/17/08Federal Court Approval for Scheme Meetings for RedomiciliationPrinter Friendly Version
09/15/08Change of Directors InterestsPrinter Friendly Version
09/11/08CE Mark SubmissionPrinter Friendly Version
09/08/08Change of Directors InterestPrinter Friendly Version
09/04/08Change of Share RegistryPrinter Friendly Version
09/03/08Cancellation of OptionsPrinter Friendly Version
09/03/08Change of Directors InterestsPrinter Friendly Version
09/03/08Change of Directors InterestsPrinter Friendly Version
08/28/08Change of Directors InterestsPrinter Friendly Version
08/27/08Change of Directors InterestsPrinter Friendly Version
08/26/08Change of Directors InterestsPrinter Friendly Version
08/25/08Change of Directors InterestsPrinter Friendly Version
08/22/08Change of Directors InterestsPrinter Friendly Version
08/21/08First U.S. ImplantPrinter Friendly Version
08/19/08Change of Directors InterestsPrinter Friendly Version
08/14/08Annual Equity AwardPrinter Friendly Version
08/14/08Change of Directors InterestsPrinter Friendly Version
08/13/08Half-Year Financial Report 30 June 2008Printer Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/12/08Canaccord Adams PresentationPrinter Friendly Version
08/05/08Proposed Redomiciliation in the United StatesPrinter Friendly Version
08/01/08First IRB Approval in the United StatesPrinter Friendly Version
07/31/08Quarterly Update and Appendix 4CPrinter Friendly Version
07/25/08Redemption of Convertible NotePrinter Friendly Version
07/11/08Change of Directors Interests - PlacementPrinter Friendly Version
07/11/08Grant of Options to Non Executive DirectorPrinter Friendly Version
07/11/08Completion of Placement A$31MPrinter Friendly Version
07/11/08Results of EGMPrinter Friendly Version
07/11/08EGM MaterialsPrinter Friendly Version
06/20/08Cancellation of OptionsPrinter Friendly Version
06/11/08SPP CancelledPrinter Friendly Version
06/04/08Notice of Extraordinary General MeetingPrinter Friendly Version
05/27/08Shareholder Share Purchase Plan UpdatePrinter Friendly Version
05/26/08Preliminary Notice of Meeting - EGMPrinter Friendly Version
05/23/08Private Placement in Excess of A$30 MillionPrinter Friendly Version
05/16/08Operational UpdatePrinter Friendly Version
05/09/082008 Annual General MeetingPrinter Friendly Version
05/09/08Results of Annual General Meeting 2008Printer Friendly Version
05/09/08Grant of Performance RightsPrinter Friendly Version
05/09/08Change of Directors InterestPrinter Friendly Version
05/08/08Change of Directors InterestsPrinter Friendly Version
05/06/08Change of Directors InterestsPrinter Friendly Version
05/05/08FDA grants conditional IDE approvalPrinter Friendly Version
05/02/08Change of Directors InterestPrinter Friendly Version
04/30/08Non-Executive Director AppointedPrinter Friendly Version
04/30/08Quarterly Update And ASX Appendix 4CPrinter Friendly Version
04/29/08Chief Medical Officer AppointePrinter Friendly Version
04/18/08New Manufacturing FacilityPrinter Friendly Version
04/18/082007 Annual ReportPrinter Friendly Version
04/14/08Clinical Data for First 23 PatientsPrinter Friendly Version
04/14/08Clinical Data for First 23 PatientsPrinter Friendly Version
04/09/08Notice of Annual General Meeting 2008Printer Friendly Version
03/26/08Draft Notice of Annual General Meeting 2008Printer Friendly Version
03/26/08Cancellation of Employee Share OptionsPrinter Friendly Version
03/04/0830th Patient - Survival UpdatePrinter Friendly Version
02/29/082007 ASX Appendix 4E - Preliminary Final ReportPrinter Friendly Version
02/29/082007 Annual Financial Report And Directors ReportPrinter Friendly Version
02/29/082007 US Annual Report (US GAAP)Printer Friendly Version
02/06/08Change of Directors InterestPrinter Friendly Version
02/05/08Change of Directors InterestPrinter Friendly Version
01/31/08Quarterly Update & 4CPrinter Friendly Version
01/27/08Incentive Option Terms for Non-Exec.Directors & Inteq LtdPrinter Friendly Version
12/19/07Shareholder UpdatePrinter Friendly Version
12/13/07Appendix 3B - ESOPPrinter Friendly Version
12/04/07Change of Address of Share RegistryPrinter Friendly Version
11/20/07Performance Rights and ESOP GrantPrinter Friendly Version
11/20/07Appendix 3B - ESOPPrinter Friendly Version
11/20/07Appendix 3B - Incentive OptionsPrinter Friendly Version
11/02/07Presentation at ISRBP ConferencePrinter Friendly Version
11/01/07Submission to FDA for Investigational Device Exemption (IDE)Printer Friendly Version
10/31/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
09/03/07Completion of Enrolment in International Clinical TrialPrinter Friendly Version
08/31/07Interim Financial Report 30 June 2007Printer Friendly Version
08/21/07Change of Directors InterestPrinter Friendly Version
08/15/07US GAAP Financial Statements - Quarter Ended 30 June 2007Printer Friendly Version
08/07/07Participant BulletinPrinter Friendly Version
07/31/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
07/26/07EGM Presentation MaterialsPrinter Friendly Version
07/26/07Results of EGMPrinter Friendly Version
07/26/07Private Placement CompletePrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/26/07Grant of Options Under ESOPPrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/26/07Change of Directors InterestPrinter Friendly Version
07/24/07First Recovery PatientPrinter Friendly Version
07/24/07Share Purchase Plan ClosedPrinter Friendly Version
07/19/07Dual Reporting RequirementsPrinter Friendly Version
07/17/07Updated Registration Statement on Form 10 - US GAAP FinancialsPrinter Friendly Version
07/13/07Clinical Trial Update - July 2007Printer Friendly Version
07/10/07Change of AddressPrinter Friendly Version
07/04/07Change of Directors' InterestPrinter Friendly Version
07/03/07Change of Directors InterestPrinter Friendly Version
06/27/07Notice of EGMPrinter Friendly Version
06/26/07Share Purchase PlanPrinter Friendly Version
06/14/07Private Placement in Excess of $30 MillionPrinter Friendly Version
05/24/07Annual General Meeting ConfirmationPrinter Friendly Version
05/23/07Annual General Meeting MaterialsPrinter Friendly Version
05/23/07Results of Annual General MeetingPrinter Friendly Version
05/01/07HeartWare Moves Towards NASDAQ ListingPrinter Friendly Version
04/30/07Quarterly Update And ASX Appendix 4CPrinter Friendly Version
04/20/07Annual Report & Notice of AGMPrinter Friendly Version
04/20/07Cancellation of ESOP OptionsPrinter Friendly Version
04/11/07First Implant at St Vincent'sPrinter Friendly Version
04/03/07Ethics Committee Approval at St Vincent's HospitalPrinter Friendly Version
04/02/07Fourth Implant Centre OpenedPrinter Friendly Version
03/22/07One Year Anniversary of First ImplantPrinter Friendly Version
03/13/07Shareholder UpdatePrinter Friendly Version
03/13/07CEO PresentationPrinter Friendly Version
02/28/07ASX Appendix 4E 31 December 2006Printer Friendly Version
02/28/072006 Annual Financial Report and Directors' ReportPrinter Friendly Version
01/31/07Quarterly Update & ASX Appendix 4CPrinter Friendly Version
01/18/07End of Restriction PeriodPrinter Friendly Version
01/18/07Appendix 3B - Exercise of ESOP OptionsPrinter Friendly Version
01/10/07First Implant at Hannover Medical CentrePrinter Friendly Version
01/03/07Grant of Options under ESOPPrinter Friendly Version
01/03/07Letter to ShareholdersPrinter Friendly Version
01/03/07Change of Directors InterestPrinter Friendly Version
12/11/06Appointment of Non Executive DirectorPrinter Friendly Version
11/29/06CEO Presentation November 2006Printer Friendly Version
11/29/06Change of Directors InterestsPrinter Friendly Version
11/22/06Executive Appointment & 5th ImplantPrinter Friendly Version
11/20/06Change of Directors InterestPrinter Friendly Version
11/06/06Change of Directors InterestPrinter Friendly Version
10/31/06Quarterly ReportPrinter Friendly Version
10/31/06Appointment of Executive DirectorPrinter Friendly Version
10/31/06Grant of OptionsPrinter Friendly Version
10/23/06First Implant at Royal PerthPrinter Friendly Version
10/23/06ASX Appendix 3BPrinter Friendly Version
10/18/06Change of Directors InterestPrinter Friendly Version
10/11/06Letter to ShareholdersPrinter Friendly Version
10/10/06Change of Directors InterestPrinter Friendly Version
10/10/06Change of Directors InterestPrinter Friendly Version
10/04/06Appendix 3BPrinter Friendly Version
10/03/06Change of Directors InterestPrinter Friendly Version
09/14/06Change of Directors InterestPrinter Friendly Version
09/04/06Appointment of New Chief Executive OfficerPrinter Friendly Version
07/31/062006 Interim Financial ReportPrinter Friendly Version
07/31/06Quarterly Cash Flow June 2006Printer Friendly Version
07/26/06ESOP GrantPrinter Friendly Version
07/07/06German Regulatory ApprovalPrinter Friendly Version
07/06/06Clarification of Option CancellationPrinter Friendly Version
07/05/06ASX Appendix 3BPrinter Friendly Version
06/20/06Change of Directors InterestPrinter Friendly Version
06/19/06Change of Directors InterestPrinter Friendly Version
06/16/06Change of Directors InterestPrinter Friendly Version
06/16/06Closing of HeartWare SPPPrinter Friendly Version
06/15/06Presentation at the Australian Biotechnology ExpoPrinter Friendly Version
06/13/06Change of Directors InterestPrinter Friendly Version
05/23/062006 Annual General Meeting PresentationPrinter Friendly Version
05/23/06Annual General Meeting ResultsPrinter Friendly Version
05/23/06Completion of Capital RaisingPrinter Friendly Version
05/22/06Regulatory Approval in the United KingdomPrinter Friendly Version
05/19/06HeartWare Shareholder Share Purchase PlanPrinter Friendly Version
05/15/06Change of Directors InterestPrinter Friendly Version
05/11/06Change of Directors InterestPrinter Friendly Version
05/10/06$32.5 Million Capital RaisingPrinter Friendly Version
04/28/06Clinical Trial Update - April 2006Printer Friendly Version
04/21/06Chief Operating Officer AppointedPrinter Friendly Version
04/20/06Annual Report 2005 and Notice of Annual General MeetingPrinter Friendly Version
04/20/06ASX Appendix 4C Quarter Ended 31 March 2006Printer Friendly Version
03/27/06Annual Financial Report and Directors Report 31 Dec 2005Printer Friendly Version
03/24/06Clinical Trials CommencePrinter Friendly Version
03/15/06Change of Directors InterestsPrinter Friendly Version
03/08/06TGA ApprovalPrinter Friendly Version
02/28/06ASX Appendix 4EPrinter Friendly Version
01/31/06ASX Appendix 4C 31 December 2005Printer Friendly Version
01/30/06Removal of FORUSPrinter Friendly Version
01/24/06Amended Director InterestsPrinter Friendly Version
01/10/06End of Restriction PeriodPrinter Friendly Version
01/05/06Regulatory ApprovalPrinter Friendly Version
01/03/06Initial Substantial Shareholder NoticePrinter Friendly Version
12/15/05Appendix 3BPrinter Friendly Version
12/01/05Change of Directors InterestPrinter Friendly Version
12/01/05ASX Appendix 3BPrinter Friendly Version
11/10/05Settlement of Patent DisputePrinter Friendly Version
11/02/05Completion of StudiesPrinter Friendly Version
10/19/05Negotiations CommencePrinter Friendly Version
10/19/05Quarterly Cash FlowPrinter Friendly Version
10/11/05Advisory Board GLP ReviewPrinter Friendly Version
09/27/05Change of Directors InterestPrinter Friendly Version
09/09/05New Medical Advisory Board AppointeePrinter Friendly Version
09/06/05Ventracor Litigation AnnouncementPrinter Friendly Version
09/06/05Change of AddressPrinter Friendly Version
08/31/05MVADPrinter Friendly Version
08/16/05CEO PresentationPrinter Friendly Version
08/02/05Defence and Counterclaim to LitigationPrinter Friendly Version
08/01/05GLP UpdatePrinter Friendly Version
07/29/05BIVAD ImplantPrinter Friendly Version
07/25/05Half Year ReportPrinter Friendly Version
07/25/05ASX Appendix 4CPrinter Friendly Version
07/22/05Shareholder UpdatePrinter Friendly Version
07/01/05Change of Directors InterestPrinter Friendly Version
07/01/05Appendix 3BPrinter Friendly Version
05/27/05Change of Director's Interest NoticePrinter Friendly Version
05/23/05Appendix 3B - Exercise of OptionsPrinter Friendly Version
05/03/05New Executive Appointments & Appendix 3BPrinter Friendly Version
03/17/05VCR release re claims on VCR's ASX announcement platformPrinter Friendly Version
03/16/05Shareholder UpdatePrinter Friendly Version
03/10/05Change of Director's Interest NoticePrinter Friendly Version
03/04/05Appointment of Chief Financial OfficerPrinter Friendly Version
03/04/05Change of Director's Interest NoticePrinter Friendly Version
02/22/05Change of Director's Interest NoticePrinter Friendly Version
02/15/05Change of Director's Interest NoticePrinter Friendly Version
02/10/05Granted first European PatentPrinter Friendly Version
02/08/05Change of Director's Interest NoticePrinter Friendly Version
02/08/05Amended Appendix 3X - Initial Director's Interest NoticePrinter Friendly Version
02/07/05Change of Director's Interest Notice x2Printer Friendly Version
02/02/05Change of Director's Interest Notice x2Printer Friendly Version
02/01/05Initial Director's Interest Notice x5Printer Friendly Version
01/28/05Correction to Admission to Official List-Issue Price AmendedPrinter Friendly Version
01/27/05ConstitutionPrinter Friendly Version
01/27/05Appendix 1A - ASX Listing Application & AgreementPrinter Friendly Version
01/27/05Convertible Note TermsPrinter Friendly Version
01/27/05Employee Share Option PlanPrinter Friendly Version
01/27/05Statement of CommitmentsPrinter Friendly Version
01/27/05Top 20 HoldersPrinter Friendly Version
01/27/05Escrow StatementPrinter Friendly Version
01/27/05Distribution SchedulePrinter Friendly Version
01/27/05Company's Letter to Australian Stock ExchangePrinter Friendly Version
01/27/05Pre-Quotation DisclosurePrinter Friendly Version
01/27/05Admission to Official ListPrinter Friendly Version
01/27/05Circular to Participating Organisations - Regulation SPrinter Friendly Version
01/27/05Circular re Commencement of Official QuotationPrinter Friendly Version
01/17/05Disclosure DocumentPrinter Friendly Version
12/17/04ProspectusPrinter Friendly Version

 
 
Copyright © HeartWare International, Inc.